Supreme Court's decision a win for generic drug makers fighting patents

Modern Heatlhcare: In deciding a case over who should have the upper hand in patent battles, the U.S. Supreme Court delivered a win to generic-drug makers and those hoping to hold down drug prices.

Monday's decision could, however, make it more difficult for makers of brand-name drugs to protect their patents, which they say allows them to invest in developing new drugs.

Read article